These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


185 related items for PubMed ID: 31087663

  • 1. Functional outcomes of the modified submandibular gland transfer procedure.
    Murray S, Chung J, Zhang H, Baker S, Jha N, Scrimger R, Debenham B, Biron V, Harris J, O'Connell D, Seikaly H.
    Laryngoscope; 2020 Apr; 130(4):925-929. PubMed ID: 31087663
    [Abstract] [Full Text] [Related]

  • 2. Modification of the submandibular gland transfer procedure.
    Marzouki HZ, Elkhalidy Y, Jha N, Scrimger R, Debenham BJ, Harris JR, O'Connell DA, Seikaly H.
    Laryngoscope; 2016 Nov; 126(11):2492-2496. PubMed ID: 27171786
    [Abstract] [Full Text] [Related]

  • 3. Phase III randomized study: oral pilocarpine versus submandibular salivary gland transfer protocol for the management of radiation-induced xerostomia.
    Jha N, Seikaly H, Harris J, Williams D, Sultanem K, Hier M, Ghosh S, Black M, Butler J, Sutherland D, Kerr P, Barnaby P.
    Head Neck; 2009 Feb; 31(2):234-43. PubMed ID: 19107948
    [Abstract] [Full Text] [Related]

  • 4. Functional outcomes related to the prevention of radiation-induced xerostomia: oral pilocarpine versus submandibular salivary gland transfer.
    Rieger JM, Jha N, Lam Tang JA, Harris J, Seikaly H.
    Head Neck; 2012 Feb; 34(2):168-74. PubMed ID: 21416547
    [Abstract] [Full Text] [Related]

  • 5. Impact of salivary gland dosimetry on post-IMRT recovery of saliva output and xerostomia grade for head-and-neck cancer patients treated with or without contralateral submandibular gland sparing: a longitudinal study.
    Wang ZH, Yan C, Zhang ZY, Zhang CP, Hu HS, Tu WY, Kirwan J, Mendenhall WM.
    Int J Radiat Oncol Biol Phys; 2011 Dec 01; 81(5):1479-87. PubMed ID: 20934262
    [Abstract] [Full Text] [Related]

  • 6. Contribution of submandibular gland and swallowing structure sparing to post-radiation therapy PEG dependence in oropharynx cancer patients treated with split-neck IMRT technique.
    Gensheimer MF, Nyflot M, Laramore GE, Liao JJ, Parvathaneni U.
    Radiat Oncol; 2016 Nov 15; 11(1):151. PubMed ID: 27846899
    [Abstract] [Full Text] [Related]

  • 7. Submandibular gland transfer for the prevention of radiation-induced xerostomia in oropharyngeal cancer: Dosimetric impact in the intensity modulated radiotherapy era.
    Kutuk T, McAllister NC, Rzepczynski AE, Williams A, Young G, Crawley MB, Rabinowits G, Kaiser A, Contreras JA, Kalman NS.
    Head Neck; 2022 May 15; 44(5):1213-1222. PubMed ID: 35243719
    [Abstract] [Full Text] [Related]

  • 8. A phase II study to assess the efficacy of amifostine for submandibular/sublingual salivary sparing during the treatment of head and neck cancer with intensity modulated radiation therapy for parotid salivary sparing.
    Rosenthal DI, Chambers MS, Weber RS, Eisbruch A.
    Semin Oncol; 2004 Dec 15; 31(6 Suppl 18):25-8. PubMed ID: 15726519
    [Abstract] [Full Text] [Related]

  • 9. The role of submandibular salivary gland transfer in preventing xerostomia in the chemoradiotherapy patient.
    Al-Qahtani K, Hier MP, Sultanum K, Black MJ.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Jun 15; 101(6):753-6. PubMed ID: 16731395
    [Abstract] [Full Text] [Related]

  • 10. Radiation-induced Xerostomia is Related to Stem Cell Dose-dependent Reduction of Saliva Production.
    van Rijn-Dekker MI, la Bastide-van Gemert S, Stokman MA, Vissink A, Coppes RP, Langendijk JA, van Luijk P, Steenbakkers RJHM.
    Int J Radiat Oncol Biol Phys; 2024 Nov 01; 120(3):772-782. PubMed ID: 38631537
    [Abstract] [Full Text] [Related]

  • 11. Xerostomia, salivary characteristics and gland volumes following intensity-modulated radiotherapy for nasopharyngeal carcinoma: a two-year follow up.
    Sim C, Soong YL, Pang E, Lim C, Walker GD, Manton DJ, Reynolds EC, Wee J.
    Aust Dent J; 2018 Jun 01; 63(2):217-223. PubMed ID: 29569726
    [Abstract] [Full Text] [Related]

  • 12. A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results.
    Chao KS, Deasy JO, Markman J, Haynie J, Perez CA, Purdy JA, Low DA.
    Int J Radiat Oncol Biol Phys; 2001 Mar 15; 49(4):907-16. PubMed ID: 11240231
    [Abstract] [Full Text] [Related]

  • 13. Anatomic study of submandibular gland transfer in an attempt to prevent postradiation xerostomia.
    Liu R, Seikaly H, Jha N.
    J Otolaryngol; 2002 Apr 15; 31(2):76-9. PubMed ID: 12019746
    [Abstract] [Full Text] [Related]

  • 14. Dose-effect relationships for the submandibular salivary glands and implications for their sparing by intensity modulated radiotherapy.
    Murdoch-Kinch CA, Kim HM, Vineberg KA, Ship JA, Eisbruch A.
    Int J Radiat Oncol Biol Phys; 2008 Oct 01; 72(2):373-82. PubMed ID: 18337023
    [Abstract] [Full Text] [Related]

  • 15. Does Submandibular Gland Sacrificing Neck Dissection Decrease Salivary Output and Quality of Life?
    Altuntaş OM, Özer F, Kuşçu O, Süslü N.
    ORL J Otorhinolaryngol Relat Spec; 2021 Oct 01; 83(5):341-346. PubMed ID: 33756490
    [Abstract] [Full Text] [Related]

  • 16. Submandibular gland-sparing radiation therapy for locally advanced oropharyngeal squamous cell carcinoma: patterns of failure and xerostomia outcomes.
    Gensheimer MF, Liao JJ, Garden AS, Laramore GE, Parvathaneni U.
    Radiat Oncol; 2014 Nov 26; 9():255. PubMed ID: 25424729
    [Abstract] [Full Text] [Related]

  • 17. Reducing xerostomia after chemo-IMRT for head-and-neck cancer: beyond sparing the parotid glands.
    Little M, Schipper M, Feng FY, Vineberg K, Cornwall C, Murdoch-Kinch CA, Eisbruch A.
    Int J Radiat Oncol Biol Phys; 2012 Jul 01; 83(3):1007-14. PubMed ID: 22056067
    [Abstract] [Full Text] [Related]

  • 18. Submandibular gland-sparing intensity-modulated radiotherapy.
    Mendenhall WM, Mendenhall CM, Mendenhall NP.
    Am J Clin Oncol; 2014 Oct 01; 37(5):514-6. PubMed ID: 22892434
    [Abstract] [Full Text] [Related]

  • 19. Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer.
    Eisbruch A, Kim HM, Terrell JE, Marsh LH, Dawson LA, Ship JA.
    Int J Radiat Oncol Biol Phys; 2001 Jul 01; 50(3):695-704. PubMed ID: 11395238
    [Abstract] [Full Text] [Related]

  • 20. MUC5B levels in submandibular gland saliva of patients treated with radiotherapy for head-and-neck cancer: a pilot study.
    Dijkema T, Terhaard CH, Roesink JM, Raaijmakers CP, van den Keijbus PA, Brand HS, Veerman EC.
    Radiat Oncol; 2012 Jun 15; 7():91. PubMed ID: 22704532
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.